Common name
formamide
IUPAC name
formamide
SMILES
C(=O)N
Common name
formamide
IUPAC name
formamide
SMILES
C(=O)N
INCHI
InChI=1S/CH3NO/c2-1-3/h1H,(H2,2,3)
FORMULA
CH3NO
Common name
formamide
IUPAC name
formamide
Molecular weight
45.041
clogP
-0.474
clogS
0.761
Frequency
0.1240
HBond Acceptor
1
HBond Donor
2
Total PolarSurface Area
43.09
Number of Rings
0
Rotatable Bond
0
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD01750 | Polaprezinc |
|
; | |
| FDBD01763 | Hydracarbazine |
|
; | For the treatment of hypertension. |
| FDBD01768 | Imidafenacin |
|
; | |
| FDBD01769 | Lixisenatide |
|
Drugs Used in Diabetes; Alimentary Tract and Metabolism; Blood Glucose Lowering Drugs, Excl. Insulins; | For lowering blood glucose level in patients with type 2 diabetes. |
| FDBD01773 | Eluxadoline |
|
Gastrointestinal Agents; | For the treatment of irritable bowel syndrome with diarrhea (IBS-D). |
| FDBD01780 | Molsidomine |
|
Vasodilator Agents; Nitric Oxide Donors; Cardiovascular System; Cardiac Therapy; Vasodilators Used in Cardiac Diseases; | |
| FDBD01784 | Pipamperone |
|
Antipsychotic Agents; Nervous System; Psycholeptics; Butyrophenone Derivatives; | Used in the treatment of schizophrenia. |
| FDBD01789 | Sacubitril |
|
Cardiovascular System; Agents Acting on the Renin-Angiotensin System; | Used in combination with valsartan to reduce the risk of cardiovascular events in patients with chronic heart failure (NYHA Class II-IV). |
| FDBD01793 | Ombitasvir |
|
Antiinfectives for Systemic Use; Direct Acting Antivirals; Antivirals for Systemic Use; | For use in combination with paritaprevir, ritonavir and dasabuvir for the treatment of HCV genotype 1, and with paritaprevir and ritonavir for the treatment of HCV genotype 4. |
| FDBD01794 | Paritaprevir |
|
Antiinfectives for Systemic Use; Direct Acting Antivirals; Antivirals for Systemic Use; | For use in combination with ombitasvir, ritonavir and dasabuvir for the treatment of HCV genotype 1, and with ombitasvir and ritonavir for the treatment of HCV genotype 4. |
361 ,
37
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 4f1l_ligand_frag_2.mol2 | 4f1l | 1 | -5.46 | C(=O)N | 3 |
| 1qf1_ligand_frag_5.mol2 | 1qf1 | 1 | -5.45 | C(=O)N | 3 |
| 2h3e_ligand_frag_2.mol2 | 2h3e | 1 | -5.45 | C(=O)N | 3 |
| 3jzi_ligand_frag_0.mol2 | 3jzi | 1 | -5.45 | NC=O | 3 |
| 3gn7_ligand_frag_1.mol2 | 3gn7 | 1 | -5.44 | C(=O)N | 3 |
| 3jzf_ligand_frag_0.mol2 | 3jzf | 1 | -5.44 | NC=O | 3 |
4319 ,
432
